Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 2153-2162

  Haller, Aurelia A ^a   Mitiku, Misrach ^a,b   MacPhail, Mia ^a  

^a MEDIMMUNE   (United States)

^b VaxGen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DRUG EFFICACY; DRUG SAFETY; GENE INSERTION SEQUENCE; GERIATRIC PATIENT; HAMSTER; HOSPITALIZATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; MORBIDITY; MORTALITY; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA TRANSLATION; VERO CELL; VIRUS ATTENUATION; VIRUS GENOME; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CELL LINE; CRICETINAE; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; NEUTRALIZATION TESTS; PARAINFLUENZA VIRUS 3, BOVINE; PARAINFLUENZA VIRUS 3, HUMAN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIROVIRUS INFECTIONS; VIRAL PROTEINS;

ANIMALIA; BOVINAE; BOVINE PARAINFLUENZA VIRUS 3; CRICETINAE; HUMAN PARAINFLUENZA VIRUS 3; INSERTION SEQUENCES; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; UNIDENTIFIED INSERTION SEQUENCE;

EID: 0043169518     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19079-0     Document Type: Article

References (18)

1. Beeler, J. A. & van Wyke Coelingh, K. (1989). Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol 63, 2941-2950.
2. Chanock, R. M. & Murphy, B. R. (1991). Past efforts to develop safe and effective RSV vaccines. In Animal Models of Respiratory Syncytial Virus Infection, pp. 35-42. Edited by B. Meignier, B. Murphy & P. Ogra. Lyon: Merieux Foundation.
3. Crowe, J. E., Jr, Bui, P. T., Davis, A. R., Chanock, R. M. & Murphy, B. R. (1994a). A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine 12, 783-790.
4. Crowe, J. E., Jr, Bui, P. T., London, W. T., Davis, A. R., Hung, P. P., Chanock, R. M. & Murphy, B. R. (1994b). Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine 12, 691-699.
5. Durbin, A. P., McAuliffe, J. M., Collins, P. L. & Murphy, B. R. (1999). Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261, 319-330.
6. Falsey, A. R., Cunningham, C. K., Barker, W. H., Kouides, R. W., Yuen, J. B., Menegus, M., Weiner, L. B., Bonville, C. A. & Betts, R. F. (1995). Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 172, 389-394.
7. Hall, C. B. (1999). Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr 135, 2-7.
8. Hall, C. B. (2001). Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344, 1917-1928.
9. Haller, A. A., Miller, T., Mitiku, M. & Coelingh, K. (2000). Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol 74, 11626-11635.
10. Haller, A. A., MacPhail, M., Mitiku, M. & Tang, R. S. (2001). A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3. Virology 288, 342-350.
11. Karron, R. A., Makhene, M., Gay, K., Wilson, M. H., Clements, M. L. Murphy, B. R. (1996). Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr Infect Dis 115, 650-654.
12. Karron, R. A., Wright P. F., Crowe, J. E., Jr, Clements-Mann, M. L., Thompson, J., Makhene, M., Casey, R. & Murphy, B. R. (1997). Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis 176, 1428-1436.
13. Martinez, I., Dopazo, J. & Melero, J. A. (1997). Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78, 2419-2429.
14. Murphy, B. R., Hall, S. L., Kulkarni, A. B., Crowe, J. E., Jr, Collins, P. L., Connors, M., Karron, R. A. & Chanock, R. M. (1994). An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res 32, 13-36.
15. Schmidt A. C., McAuliffe, J. M., Huang, A., Surman, S. R., Bailly, J. E., Elkins, W. R., Collins, P. L., Murphy, B. R. & Skiadopoulos, M. H. (2000). Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J Virol 74, 8922-8929.
16. Schmidt, A. C., McAuliffe, J. M., Murphy, B. R. & Collins, P. L. (2001). Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. J Virol 75, 4594-4603.
17. Schmidt, A. C., Wenzke, D. R., McAuliffe, J. M., St Claire, M., Elkins, W. R., Murphy, B. R. & Collins, P. L. (2002). Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. J Virol 76, 1089-1099.
18. Skiadopoulos, M. H., Surman, S. R., Durbin, A. P., Collins, P. L. & Murphy, B. R. (2000). Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes. Virology 272, 225-234.